FDA Investigator Edward H Maticka

Edward H Maticka has conducted inspections on 136 sites in 1 countries as of 30 Aug 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
136
Last Inspection Date:
30 Aug 2006
Investigator Role:
FDA Investigator
Redica ID:
100007356
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Edward H Maticka:
Albert A Salvador, Amanda K Willey, Andrew Saunders, Angela E Glenn, Ann B Borromeo, Anna E Fain, Benjamin E Bowen, Bonnie E Conley, Bonnie E Pierson, Brandon C Heitmeier, Brandon C Hernandez, Brittny C Cargo, Brittny M Mitchell, Brunilda Torres, Burnell M Henry, Caitlin L Almonrode, Carl A Huffman, III, Carla A Norris, Carolyn E Barney, CDR Ileana Barreto Pettit, Charles R Cote, RIC, Chauncey A Stephens, Cherie T Parker, Cheryl G Scott, Christos G Tsingelis, Claire M Minden, Clendening, Clifton C Francis, Clinton J Lott, Cynthia L Medlin, Daniel L Aisen, Daryl A Dewoskin, David R Heiar, Demario L Walls, Dennis Cantellops Paite, Dr. Dominick Roselle, Dyvette Arline, Eddie J Rigsby, Elizabeth D Connell, Fabian Nchaparro Rodriguez, Francis A Guidry, George J Flynn, Geraldine D Sanders, Gretchen M Laws, Holly M Scott, Hultman, Iris C Macinnes, Ivis L Negron, Ivy E Sweeney, James W Blakely, Jamie P Webb, Jared P Stevens, Jason D Abel, Javelle P Spann, Jennifer A Robinson, Jennifer Lalama, Jessica A Stephens, Jessica L Pressley, Joanne E King, Jogy George, Jose M Gonzalez, Jose Perez Soto, Jose Velez, Joshua J Silvestri, June P Page, Justin N Henson, Karen Gale Sego, Kayla V Sprague, Kelly I Anderson, Kenneth R Merritt, Kimberly L Mcmillan, Krista W Whitten, Laura L Staples, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Michael H Tollon, Lesley K Satterwhite, Libia M Lugo, Linda A Gregory Duty, Lindsay H Bertling, Llopis, Lourdes Andujar, LT Kimberly M Hull, Luis Mburgos Medero, Lynne Ensor, Mahaffey, Margaret E Slimbach, Marie F Morin, Mark E Parmon, Mark W Rivero, Marshall H Kinsey, Martrice A Packer, Marvin D Jones, Mary A Millner, Matthew B Thomaston, Melanie M Walker, Meocha V Whaley, Miguel A Martinez Perez, Mihaly S Ligmond, Monica Cburgos Garcia, Moraima Jramos Valle, Nadia V Simmons, Nicole E Knowlton, Noreen Muñiz, Pamela M Thomas, Paul A Bonneau, Paul L Figarole, Jr, Pifer, Reba A Gates, Regan T Harp, Richard K Vogel, Robert E Hultman, Rosario D'costa, Saleem A Akhtar, Salvatore N Randazzo, Samantha J Bradley, Sharon K Thoma, PharmD, Shrikant N Pagay, Sonia M Monges, Stephen G Mclane, Steven A Brettler, Steven D Dittert, Susan O Oladeji, Tammara A Stephens, Thomas B Smith, Thomas O Morgan, Timothy H Vo, Tracy J Washington, Travis E Chapman, Veronica Fuentes, MS, Wanda B Coats, Wendy R Blame, Zada L Giles

Edward H Maticka's Documents

Publish Date Document Type Title
February, 2003 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2003-02-13
November, 2002 FDA 483 Richard K. McDavid, MD - Form 483, 2002-11-21
January, 2003 FDA 483 Crown Laboratories, Inc. - Form 483, 2003-01-14
June, 2002 EIR Pharma Packaging Solutions, LLC dba Tjoapack, LLC - EIR, 2002-06-12
May, 2005 EIR Bayer Healthcare LLC - EIR, 2005-05-04
December, 2004 EIR Galbraith Laboratories, Inc. - EIR, 2007-04-12
October, 2000 EIR Brant-Wald Surgicals Inc - EIR, 2000-10-25
December, 2001 FDA 483 Response Cush Medical Products PSC - Form 483R, 2002-01-07
February, 2005 FDA 483 Eastman Chemical Company - Form 483, 2005-02-10
June, 2006 FDA 483 Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483, 2006-06-23
July, 2003 FDA 483 Tri-State Analytical Laboratory LLC - Form 483, 2003-07-25
January, 2004 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2004-01-23
June, 2003 EIR HILL DERMACEUTICALS, INC. - EIR, 2003-06-10
November, 2002 EIR Richard K. McDavid, MD - EIR, 2002-11-21
August, 2001 EIR USAntibiotics, LLC - EIR, 2001-08-08
September, 2004 FDA 483 Chattem Chemicals, Inc. - Form 483, 2004-09-17
February, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-02-20
February, 2001 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2001-02-02
June, 2002 FDA 483 Pharma Packaging Solutions, LLC dba Tjoapack, LLC - Form 483, 2002-06-12
July, 2004 FDA 483 Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483, 2004-07-16
June, 2000 EIR Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - EIR, 2000-06-16
May, 2000 FDA 483 Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals - Form 483, 2000-05-12
February, 2001 EIR Qualitest Pharmaceuticals - EIR, 2001-02-02
May, 2000 EIR Qualitest Pharmaceuticals - EIR, 2000-05-12
June, 2003 EIR Catalent Pharma Solutions, LLC - EIR, 2003-06-27
July, 2002 EIR Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - EIR, 2002-07-02
September, 2002 FDA 483 Galbraith Laboratories, Inc. - Form 483, 2002-09-25
August, 2003 FDA 483 USAntibiotics, LLC - Form 483, 2003-08-19
August, 2000 EIR Eastman Chemical Company - EIR, 2000-08-17
August, 2003 EIR USAntibiotics, LLC - EIR, 2003-08-19
March, 2002 EIR TriRx Huntsville Pharmaceutical Services, LLC - EIR, 2002-03-29
December, 2004 FDA 483 Galbraith Laboratories, Inc. - Form 483, 2004-12-22
December, 2004 FDA 483 Venture Tech, Inc. - Form 483, 2004-12-06
May, 2005 FDA 483 Bayer Healthcare LLC - Form 483, 2005-05-04
July, 2002 FDA 483 Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483, 2002-07-02
June, 2006 FDA 483 Response Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483R, 2006-07-21
December, 2001 FDA 483 Cush Industries Inc. - Form 483, 2001-12-13
May, 2006 EIR Eastman Chemical Company - EIR, 2006-05-26
August, 2001 FDA 483 Smith Kline Beechan Corp. - Form 483, 2001-08-08
July, 2004 FDA 483 Qualitest Pharmaceuticals - Form 483, 2004-07-02
March, 2002 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2002-03-29
March, 2001 EIR Wortham, Dale C. MD - EIR, 2001-03-27
April, 2000 EIR Galbraith Laboratories, Inc. - EIR, 2000-04-24
April, 2000 FDA 483 Galbraith Laboratories, Inc. - Form 483, 2000-04-24
June, 2003 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2003-06-27
October, 2000 FDA 483 Brant-Wald Surgicals Inc - Form 483, 2000-10-25
June, 2000 FDA 483 Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483, 2000-06-16
April, 2000 FDA 483 Response Galbraith Laboratories, Inc. - Form 483R, 2000-05-09
May, 2001 EIR Eastman Chemical Company - EIR, 2001-06-05
May, 2006 FDA 483 Eastman Chemical Company - Form 483, 2006-05-26
September, 2002 EIR Galbraith Laboratories, Inc. - EIR, 2002-09-25
March, 2001 FDA 483 Response Wortham, Dale C. MD - Form 483R, 2001-04-02
February, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-02-08
February, 2001 FDA 483 Response Qualitest Pharmaceuticals - Form 483R, 2001-02-06
May, 2000 FDA 483 Response Qualitest Pharmaceuticals - Form 483R, 2000-06-09
September, 2002 EIR RbM Services LLC - EIR, 2002-09-17
June, 2000 FDA 483 Response Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483R, 2000-07-10
August, 2001 FDA 483 SAGE PHARMACEUTICALS, INC. - Form 483, 2001-08-31
September, 2003 FDA 483 Venture Tech, Inc. - Form 483, 2003-09-29
February, 2003 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2003-02-13
May, 2001 FDA 483 Midlab Inc. - Form 483, 2001-05-11
December, 2004 FDA 483 Galbraith Laboratories, Inc. - Form 483, 2004-12-22
August, 2005 FDA 483 Melaleuca Inc - Form 483, 2005-08-10
June, 2002 FDA 483 Response Pharma Packaging Solutions, LLC dba Tjoapack, LLC - Form 483R, 2002-07-03
December, 2001 EIR Cush Medical Products PSC - EIR, 2001-12-13
April, 2004 FDA 483 Crown Laboratories, Inc. - Form 483, 2004-04-21
March, 2001 FDA 483 Wortham, Dale C. MD - Form 483, 2001-03-27
June, 2006 EIR Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - EIR, 2006-06-23
August, 2001 FDA 483 Response USAntibiotics, LLC - Form 483R, 2001-09-10
December, 2003 FDA 483 Deroyal Technologies Inc - Form 483, 2003-12-09
August, 2000 FDA 483 Eastman Chemical Company - Form 483, 2000-08-17
May, 2001 EIR Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - EIR, 2001-05-24
August, 2006 FDA 483 Chattem Chemicals, Inc. - Form 483, 2006-08-04
July, 2002 FDA 483 Response Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals - Form 483R, 2002-08-08
March, 2002 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2002-04-19
February, 2005 EIR Eastman Chemical Company - EIR, 2005-02-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more